OrthoPediatrics amends distribution agreement with Bioretec: 5 things to know

Written by Mackenzie Garrity | November 14, 2017 | Print  |

OrthoPediatrics and Bioretec amended their existing distribution agreement.

Here are five things to know:


1. Under the new agreement, OrthoPediatrics will market and sell Bioretec's orthopedic bone and soft tissue fixation implants under OrthoPediatric's brand TorqLoc.


2. Bioretec's bioresorbable implants are designed for repairing musculoskeletal defects in children and young adults. Clinical studies have shown the implants positively repair growing bones.


3. Bioretec is a material technology company focused on developing and manufacturing bioabsorbable and bioactive surgical implants for orthopedic, trauma and sports medicine surgeries.


4. OrthoPediatrics currently markets 22 surgical systems, serving three of the largest categories within the pediatric orthopedic market: trauma and deformity, complex spine and ACL reconstruction.


5. OrthoPediatrics' Vice President of Trauma and Deformity Correction Joe Hauser said, "This evolving strategic partnership and collaboration with Bioretec represents another area for tremendous growth within OrthoPediatrics' portfolio. The TorqLoc screw portfolio will provide a truly innovative option for many unmet

pediatric orthopedic sports and tissue repair surgical needs."


More articles on devices and implants:
Eliminating the 'price of doing business': How Olympus' ORBEYE is minimizing surgeon fatigue during spine surgery
Artificial joints market to see 5.53% CAGR through 2021: 4 insights
Australia's Therapeutic Goods Administration seeks to tighten 3-D printed implant regulations

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months